Cited by 3,559Angiogenesis and VEGF in CancerCancer Cells and MetastasisMathematical Biology Tumor Growth

The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.

Tumorigenesis and the angiogenic switch

Bergers, Gabriele, Benjamin, Laura E.·2003·Nature reviews. Cancer

Open this paper in CoChat — free account

Abstract

It has become evident that we cannot understand tumour growth without considering components of the stromal microenvironment, such as the vasculature. At the same time, the tumour phenotype determines the nature of the tumour vasculature. Much research is now devoted to determining the impact of angiogenesis on tumour development and progression, and the reciprocal influences of tumour products on the microvasculature. A more detailed understanding of the complex parameters that govern the interactions between the tumour and vascular compartments will help to improve anti-angiogenic strategies-- not only for cancer treatment, but also for preventing recurrence.

Integrity signals

Registry

Crossref · 10.1038/nrc1093

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis
Watnick, R. S., Cheng, Y.-N., Rangarajan, A., Ince, T. A., & Weinberg, R. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00030-8 · Cited by 318
Retracted
The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., de Vries-Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,704
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,235
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699

Show all 110 references

Research works printed but not linked: 2

Folkman, J. in Cancer Medicine (Holland, M.D. et al.) 2546 (BC Decker, Hamilton, Ontario, 2000).
Sternlicht, M. D. et al. Matrix proteinases as emerging targets in anticancer therapy: status and prospects. ETT 4, 609–633 (2000).

Sorted by citations

Items 801–900 of 1,010

Intermittent hypoxia changes HIF-1α phosphorylation pattern in endothelial cells: Unravelling of a new PKA-dependent regulation of HIF-1α
Toffoli, S., Féron, O., Raes, M. J., & Michiels, C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.06.002 · Cited by 69
Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades
Белоусова, Е. Л., Karmazanovsky, G. G., Kriger, A. G., Kalinin, D. V., Mannelli, L., Glotov, A. V., Karelskaya, N. A., Paklina, O. V., & Kaldarov, A. R. (2016) · Clinical Radiology · doi:10.1016/j.crad.2016.10.021 · Cited by 65
Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance
Dzobo, K., & Dandara, C. (2020) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2020.0023 · Cited by 65
“Migration and invasion of tumor cells into the surrounding tissues induce angiogenesis as well (Bergers and Benjamin, 2003).”
Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma
Guo, L., Wang, Z., Du, Y., Mao, J., Zhang, J., Yu, Z., Guo, J., Zhao, J., Zhou, H., Wang, H., et al. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01274-z · Cited by 67
β-Caryophyllene Induces Apoptosis and Inhibits Angiogenesis in Colorectal Cancer Models
Dahham, S. S., Tabana, Y., Asif, M., Ahmed, M., Babu, D., Hassan, L. E. A., Ahamed, M. B. K., Sandai, D. A., Barakat, K., Siraki, A. G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910550 · Cited by 65
Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2
Ohradanova‐Repic, A., Gradin, K., Baráthová, M., Zaťovičová, M., Holotnakova, T., Kopáček, J., Parkkila, S., Poellinger, L., Pastoreková, S., & Pastorek, J. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604685 · Cited by 65
Autophagy inhibition suppresses the tumorigenic potential of cancer stem cell enriched side population in bladder cancer
Ojha, R., Jha, V., Singh, S. K., & Bhattacharyya, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.07.007 · Cited by 68
Angiogenesis inhibitors in the treatment of prostate cancer
Hwang, C., & Heath, E. I. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-26 · Cited by 67
Role of hypoxia and vascular endothelial growth factors in lymphangiogenesis
Morfoisse, F., Renaud-Gabardos, E., Hantelys, F., Prats, A., & Garmy-Susini, B. H. (2014) · Molecular & Cellular Oncology · doi:10.4161/mco.29907 · Cited by 68
Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis
Bhise, N. S., Shmueli, R. B., Sunshine, J. C., Tzeng, S. Y., & Green, J. J. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.558082 · Cited by 65
Distinct contributions of angiogenesis and vascular co-option during the initiation of primary microtumors and micrometastases
Zhao, C., Yang, H., Shi, H., Wang, X., Chen, X., Yuan, Y., Lin, S., & Wei, Y. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr076 · Cited by 65
Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity
Eikesdal, H. P., Sugimoto, H., Birrane, G., Maeshima, Y., Cooke, V. G., Kieran, M. W., & Kalluri, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807055105 · Cited by 68
Angiopoietin-4 Promotes Glioblastoma Progression by Enhancing Tumor Cell Viability and Angiogenesis
Brunckhorst, M. K., Wang, H., Lu, R., & Yu, Q. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4125 · Cited by 66
Mesoporous Silica Nanoparticles as an Antitumoral-Angiogenesis Strategy
Setyawati, M. I., & Leong, D. T. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b12524 · Cited by 65
AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells
Zhang, W., Wu, Q., Wang, C., Yang, L., Liu, P., & Ma, C. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3335-7 · Cited by 65
Melatonin restrains angiogenic factors in triple-negative breast cancer by targeting miR-152-3p: In vivo and in vitro studies
Marques, J. H. D. M., Mota, A. L., de Oliveira, J. G., Lacerda, J. Z., Stefani, J. P., Ferreira, L. C., de Castro, T. B., Aristizábal-Pachón, A. F., & Zuccari, D. A. P. D. C. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.07.012 · Cited by 65
Targeting endothelial metabolism for anti-angiogenesis therapy: A pharmacological perspective
Missiaen, R., Morales-Rodriguez, F., Eelen, G., & Carmeliet, P. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.01.001 · Cited by 58
Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind αvβ3 integrin, leading to anti-angiogenic and anti-tumor effects
Son, H., Nam, J.-O., Kim, S., & Kim, I.-S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.012 · Cited by 61
Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats
Yoshiji, H., Noguchi, R., Kitade, M., Kaji, K., Ikenaka, Y., Namisaki, T., Yoshii, J., Yanase, K., Yamazaki, M., Tsujimoto, T., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0031-0 · Cited by 64
Gene editing and synthetically accessible inhibitors reveal role for TPC2 in HCC cell proliferation and tumor growth
Müller, M. J., Gerndt, S., Chao, Y., Zisis, T., Nguyen, O. N. P., Gerwien, A., Urban, N. D., Müller, C., Gegenfurtner, F. A., Geisslinger, F., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.01.023 · Cited by 66
Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits
Maneshi, P., Mason, J. E., Dongre, M., & Öhlund, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.787485 · Cited by 68
Angiogenesis: From Chronic Liver Inflammation to Hepatocellular Carcinoma
Sanz-Cameno, P., Trapero-Marugán, M., Chaparro, M., Jones, E. A., & Moreno‐Otero, R. (2010) · Journal of Oncology · doi:10.1155/2010/272170 · Cited by 64
Brain Metastases: Epidemiology and Pathophysiology
Sul, J., & Posner, J. B. (2007) · Cancer treatment and research · doi:10.1007/978-0-387-69222-7_1 · Cited by 65
Metronomic chemotherapy: an antiangiogenic scheduling
Laquente, B., Viñals, F., & Germà, J. R. (2007) · Clinical & Translational Oncology · doi:10.1007/s12094-007-0018-3 · Cited by 64
Forkhead Transcription Factor FOXO3a Protein Activates Nuclear Factor κB through B-cell lymphoma/leukemia 10 (BCL10) Protein and Promotes Tumor Cell Survival in Serum Deprivation
Li, Z., Zhang, H., Chen, Y., Li, F., & Fang, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.291708 · Cited by 66
Phosphorylation of αB-crystallin: Role in stress, aging and patho-physiological conditions
Raman, B., Akula, K. K., Ramakrishna, T., & Rao, C. M. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.09.017 · Cited by 64
Cancer-Associated Intermediate Conductance Ca2+-Activated K+ Channel KCa3.1
Mohr, C. J., Steudel, F. A., Gross, D., Ruth, P., Lo, W., Hoppe, R., Schroth, W., Brauch, H. B., Huber, S. M., & Łukowski, R. (2019) · Cancers · doi:10.3390/cancers11010109 · Cited by 64
Tumor progression-dependent angiogenesis in gastric cancer and its potential application
Hsieh, H., & Tsai, M.-M. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v11.i9.686 · Cited by 66
The Potential of Antiangiogenic Therapy in Non–Small Cell Lung Cancer
Giaccone, G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2186 · Cited by 64
Upregulation of α enolase (ENO1) crotonylation in colorectal cancer and its promoting effect on cancer cell metastasis
Hou, J., Cao, J., Gao, L., Zhang, F., Shen, J., Zhou, L., Shi, J., Feng, Y., Yan, Z., Wang, D., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.09.027 · Cited by 63
Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis
Do, M. H., Shi, W., Ji, L., Ladewig, E., Zhang, X., Srivastava, R. M., Capistrano, K. J., Edwards, C., Malik, I., Nixon, B. G., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.10.010 · Cited by 64
Model-based angiogenic inhibition of tumor growth using modern robust control method
Kovács, L., Szeles, A., Sápi, J., Drexler, D. A., Rudas, I. J., Harmati, I., & Sápi, Z. (2014) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2014.01.002 · Cited by 63
“[30] G.”
Background
The Kunitz-Like Modulatory Protein Haemangin Is Vital for Hard Tick Blood-Feeding Success
Islam, M. K., Tsuji, N., Miyoshi, T., Alim, M. A., Huang, X., Hatta, T., & Fujisaki, K. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000497 · Cited by 63
Multiscale Imaging and Computational Modeling of Blood Flow in the Tumor Vasculature
Kim, E., Stamatelos, S. K., Cebulla, J., Bhujwalla, Z. M., Popel, A. S., & Pathak, A. P. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-012-0585-5 · Cited by 63
Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer
Dango, S., Sienel, W. G. R., Schreiber, M., Stremmel, C., Kirschbaum, A., Pantel, K., & Passlick, B. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2007.11.015 · Cited by 63
MicroRNAs: Promising New Antiangiogenic Targets in Cancer
Gallach, S., Fariñas, S. C., Lewintre, E. J., & Camps, C. (2014) · BioMed Research International · doi:10.1155/2014/878450 · Cited by 64
The utility of Aspirin in dukes C and high risk dukes B colorectal cancer - The ASCOLT study: study protocol for a randomized controlled trial
Ali, R., Toh, H.-C., Chia, W.-K. J., & The ASCOLT trial investigators (2011) · Trials · doi:10.1186/1745-6215-12-261 · Cited by 64
Multimodality Tumor Imaging Targeting Integrin α v β 3
Cai, W., Gambhir, S. S., & Chen, X. S. (2005) · BioTechniques · doi:10.2144/000112091 · Cited by 63
WISP-1, a novel angiogenic regulator of the CCN family, promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression
Chuang, J., Chen, P., Tsao, C.-W., Chang, A., Lein, M., Lin, C.-C., Wang, S., Lin, C., & Tang, C. (2015) · Oncotarget · doi:10.18632/oncotarget.2978 · Cited by 62
Adipocytes: active facilitators in epithelial ovarian cancer progression?
Dai, L., Song, K., & Di, W. J. (2020) · Journal of Ovarian Research · doi:10.1186/s13048-020-00718-4 · Cited by 63
Molecular Pathogenesis of Glioblastoma in Adults and Future Perspectives: A Systematic Review
Esemen, Y., Awan, M., Parwez, R., Baig, A., Rahman, S., Masala, I., Franchini, S., & Giakoumettis, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052607 · Cited by 64
3D microengineered vascularized tumor spheroids for drug delivery and efficacy testing
Ahn, J., Kim, D., Koo, D.-J., Lim, J., Park, T., Lee, J., Ko, J., Kim, S., Kim, M., Kang, K., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.10.009 · Cited by 64
CXCR4 and CXCR7 regulate angiogenesis and CT26.WT tumor growth independent from SDF‐1
Kollmar, O., Rupertus, K., Scheuer, C., Nickels, R. M., Haberl, G. C. Y., Tilton, B., Menger, M. D., & Schilling, M. K. (2009) · International Journal of Cancer · doi:10.1002/ijc.24956 · Cited by 62
Regulating the angiogenic balance in tissues: A potential role for the proliferative state of fibroblasts
Pollina, E. A., Legesse-Miller, A., Haley, E. M., Goodpaster, T. A., Randolph‐Habecker, J., & Coller, H. A. (2008) · Cell Cycle · doi:10.4161/cc.7.13.6240 · Cited by 61
Angiogenesis and Anti-Angiogenic Molecularly Targeted Therapies in Malignant Gliomas
Argyriou, A. A., Giannopoulou, E., & Kalofonos, H. P. (2009) · Oncology · doi:10.1159/000218165 · Cited by 61
Inhibition of angiogenesis and invasion in malignant gliomas
Chi, A. S., Norden, A. D., & Wen, P. Y. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.11.1537 · Cited by 63
Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours
Cappelli, C., Boggi, U., Mazzeo, S., Cervelli, R., Campani, D., Funel, N., Contillo, B. P., & Bartolozzi, C. (2014) · European Radiology · doi:10.1007/s00330-014-3485-2 · Cited by 62
Liposome–DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma
Kamstock, D. A., Guth, A., Elmslie, R. E., Kurzman, I. D., Liggitt, D., Coro, L., Fairman, J., & DOW, S. W. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700895 · Cited by 62
Vascular Endothelial Growth Factor and Vascular Homeostasis
Lazarus, A., & Keshet, E. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201102-021mw · Cited by 64
Anti-angiogenic gene therapy in the treatment of malignant gliomas
Gatson, N. T., Chiocca, E. A., & Kaur, B. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.08.001 · Cited by 62
The role of the RhoA/Rho kinase pathway in angiogenesis and its potential value in prostate cancer (Review)
Chen, W., Mao, K., Liu, Z., & Dinh‐Xuan, A. T. (2014) · Oncology Letters · doi:10.3892/ol.2014.2471 · Cited by 61
Targeting Angiogenesis in Biliary Tract Cancers: An Open Option
Simone, V. D., Brunetti, O., Lupo, L., Testini, M., Maiorano, E., Simone, M. D., Longo, V., Rolfo, C. D., Peeters, M., Scarpa, A., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020418 · Cited by 61
Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope?
Castet, F., García‐Mulero, S., Pamplona, R. S., Cuellar, A., Casanovas, O., Mitjana, J. M. C., & Piulats, J. M. (2019) · Cancers · doi:10.3390/cancers11060834 · Cited by 64
A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, αVβ3/αVβ5 and MMP-2/-9
Sun, L., Luo, J., Mackey, L. V., Fuselier, J. A., & Coy, D. H. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.02.016 · Cited by 62
Irinotecan therapy and molecular targets in colorectal cancer: A systemic review
Weekes, J., Lam, A. K.-Y., Sebesan, S., & Ho, Y. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.3597 · Cited by 62
Liver endothelial cells in NAFLD and transition to NASH and HCC
Velliou, R.-I., Legaki, A., Nikolakopoulou, P., Vlachogiannis, N. I., & Chatzigeorgiou, A. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04966-7 · Cited by 64
“Angiogenesis is essential for a variety of cellular processes, growth and spread of tumour cells [159].”
Background
Microenvironment Changes (in pH) Affect VEGF Alternative Splicing
Elias, A. P., & Dias, S. (2008) · Cancer Microenvironment · doi:10.1007/s12307-008-0013-4 · Cited by 64
TWEAK and Fn14: New molecular targets for cancer therapy?
Winkles, J. A., Tran, N. L., & Berens, M. E. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.03.048 · Cited by 61
Imaging aspects of the tumor stroma with therapeutic implications
Narunsky-Haziza, L., Oren, R., Bochner, F., & Neeman, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.003 · Cited by 59
Engineered Conformation-dependent VEGF Peptide Mimics Are Effective in Inhibiting VEGF Signaling Pathways
Vicari, D., Foy, K. C., Liotta, E. M., & Kaumaya, P. T. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.216812 · Cited by 61
Synthesis, Antimitotic and Antivascular Activity of 1-(3′,4′,5′-Trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles
Romagnoli, R., Baraldi, P. G., Salvador, M. K., Prencipe, F., Bertolasi, V., Cancellieri, M., Brancale, A., Hamel, E., Castagliuolo, I., Consolaro, F., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5008193 · Cited by 61
Antitumor Activity of Targeting Src Kinases in Endothelial and Myeloid Cell Compartments of the Tumor Microenvironment
Liang, W. P., Kujawski, M., Wu, J., Lu, J., Herrmann, A., Loera, S., Yen, Y., Lee, F., Yu, H., Wen, W. X., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1486 · Cited by 61
In vivo growth inhibitory and anti-angiogenic effects of synthetic novel dienone cyclopropoxy curcumin analogs on mouse Ehrlich ascites tumor
Chandru, H. K., Sharada, A. C., Bettadaiah, B. K., Kumar, C. S. A., Rangappa, K. S., Sunila, & Jayashree, K. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.08.051 · Cited by 61
Differential effects of matrix and growth factors on endothelial and fibroblast motility: Application of a modified cell migration assay
van Horssen, R., Galjart, N., Rens, J. A. P., Eggermont, A. M. M., & ten Hagen, T. L. M. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20994 · Cited by 61
The roles and role-players in thyroid cancer angiogenesis
Rajabi, S., Dehghan, M. H., Dastmalchi, R., Mashayekhi, F. J., Salami, S., & Hedayati, M. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0537 · Cited by 63
TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor MicroenvironmentPreprint
Pickup, M. W., Owens, P., & Moses, H. L. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022285 · Cited by 63
A multilayered blood vessel/tumor tissue chip to investigate T cell infiltration into solid tumor tissues
Lee, J., Kim, S.-E., Moon, D., & Doh, J. (2021) · Lab on a Chip · doi:10.1039/d1lc00182e · Cited by 59
Stat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cells
Lee, H., Xue, J., Chou, P., Zhou, A., Yang, P., Conrad, C. A., Aldape, K., Priebe, W., Patterson, C., Sawaya, R. A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3540 · Cited by 64
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia
Bottos, A., Martini, M., Nicolantonio, F. D., Comunanza, V., Maione, F., Minassi, A., Appendino, G., Bussolino, F., & Bardelli, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105026109 · Cited by 61
Pharmacokinetics and excretion of 14C-lenvatinib in patients with advanced solid tumors or lymphomas
Dubbelman, A.-C., Rosing, H., Nijenhuis, C. M., Huitema, A. D. R., Mergui‐Roelvink, M., Gupta, A., Verbel, D., Thompson, G. A., Shumaker, R., Schellens, J. H. M., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0181-7 · Cited by 60
Tumor Uptake of the RGD Dimeric Probe 99mTc-G3-2P4-RGD2 is Correlated with Integrin αvβ3 Expressed on both Tumor Cells and Neovasculature
Liu, Z., Jia, B., Shi, J., Jin, X., Zhao, H., Li, F., Liu, S., & Wang, F. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900547d · Cited by 60
Macrophage Migration Inhibitory Factor: a Potential Marker for Cancer Diagnosis and Therapy
Babu, S. N., Chetal, G., & Kumar, S. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.5.1737 · Cited by 60
The potential of anti-vascular endothelial growth factor therapy in metastatic breast cancer: Clinical experience with anti-angiogenic agents, focusing on bevacizumab
Marty, M. E., & Pivot, X. B. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.01.005 · Cited by 60
The Vascular Targeting Property of Paclitaxel Is Enhanced by SU6668, a Receptor Tyrosine Kinase Inhibitor, Causing Apoptosis of Endothelial Cells and Inhibition of Angiogenesis
Naumova, E., Ubezio, P., Garofalo, A., Borsotti, P., Cassis, L., Riccardi, E., Scanziani, E., Eccles, S. A., Bani, M. R., & Giavazzi, R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1615 · Cited by 60
Notch Regulation of Tumor Angiogenesis
Bridges, E., Oon, C. E., & Harris, A. L. (2011) · Future Oncology · doi:10.2217/fon.11.20 · Cited by 60
Angiocrine Factors Modulate Tumor Proliferation and Motility through EphA2 Repression of Slit2 Tumor Suppressor Function in Endothelium
Brantley‐Sieders, D. M., Dunaway, C. M., Rao, M., Short, S. P., Hwang, Y., Gao, Y., Li, D., Jiang, A., Shyr, Y., Wu, J. Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-3396 · Cited by 60
Tumor growth or regression: powered by inflammation
Nelson, D. J., & Ganß, R. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105646 · Cited by 60
Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinases
Wille, C., Köhler, C., Armacki, M., Jamali, A., Gößele, U., Pfizenmaier, K., Seufferlein, T. T. W., & Eiseler, T. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-06-0334 · Cited by 60
Forkhead box Q1: A key player in the pathogenesis of tumors (Review)
Yang, L., Zhang, Y., Yao, Z., Li, S., Yin, Z., & Xu, M. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3517 · Cited by 59
Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances
Casey, L., & Singh, N. (2019) · Histopathology · doi:10.1111/his.13985 · Cited by 60
The Role of Anti-angiogenesis in the Treatment Landscape of Non-small Cell Lung Cancer – New Combinational Approaches and Strategies of Neovessel Inhibition
Daum, S., Hagen, H., Naismith, E., Wolf, D. G. F., & Pircher, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.610903 · Cited by 60
Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity
Asosingh, K., Raeve, H. D., Menu, E., Riet, I. V., Marck, E. V., Camp, B. V., & Vanderkerken, K. (2003) · Blood · doi:10.1182/blood-2003-08-2946 · Cited by 60
Long intergenic non-coding RNA 668 regulates VEGFA signaling through inhibition of miR-297 in oral squamous cell carcinoma
Zhang, C.-Z. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.155 · Cited by 59
Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies
Klemba, A., Bodnar, L., Waś, H., Brodaczewska, K. K., Wcisło, G., Szczylik, C. A., & Kiéda, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249492 · Cited by 59
Carbon Ions for Hypoxic Tumors: Are We Making the Most of Them?
Sokol, O., & Durante, M. (2023) · Cancers · doi:10.3390/cancers15184494 · Cited by 58
Microenvironmental regulation of solid tumour resistance to CAR T cell therapy
Lamplugh, Z. L., Wellhausen, N., June, C. H., & Fan, Y. (2025) · Nature reviews. Immunology · doi:10.1038/s41577-025-01229-3 · Cited by 76
“vasculature and into the tumour by overexpressing vascular endothelial growth factor (VEGF) and other molecules, thereby inducing the downregulation of adhesion molecules that are required for leukocyte extravasation, including intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion molecule 1 (VCAM1) 6–9…”
Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy
Bizama, C., García, P., Espinoza, J. A., Weber, H. L., Leal, P., Nervi, B., & Roa, J. C. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.01.003 · Cited by 59
Grape seed proanthocyanidins inhibit colon cancer-induced angiogenesis through suppressing the expression of VEGF and Angl
Huang, S., Yang, N., Liu, Y., Gao, J., Huang, T., Hu, L., Zhao, J., Li, Y., Li, C., & Zhang, X. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1147 · Cited by 61
VEGF-A165 Induces Human Aortic Smooth Muscle Cell Migration by Activating Neuropilin-1-VEGFR1-PI3K Axis
Banerjee, S., Mehta, S., Haque, I., Sengupta, K., Dhar, K., Kambhampati, S., Veldhuizen, P. J. V., & Banerjee, S. K. (2008) · Biochemistry · doi:10.1021/bi8000352 · Cited by 59
Targeting Tumor Microenvironment with Silibinin: Promise and Potential for a Translational Cancer Chemopreventive Strategy
Deep, G., & Agarwal, R. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113139990041 · Cited by 59
Mechanisms of Disease: angiogenesis in urologic malignancies
Charlesworth, P. J. S., & Harris, A. L. (2006) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0434 · Cited by 59
CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation
Gerstel, D., Wegwitz, F., Jannasch, K., Ludewig, P., Scheike, K., Alves, F., Beauchemin, N., Deppert, W., Wagener, C., & Horst, A. K. (2011) · Oncogene · doi:10.1038/onc.2011.146 · Cited by 60
Signal pathway profiling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition
Sheehan, K. M., Gulmann, C., Eichler, G. S., Weinstein, J. N., Barrett, H. L., Kay, E. W., Conroy, R. M., Liotta, L. A., & Petricoin, E. F. (2007) · Oncogene · doi:10.1038/sj.onc.1210647 · Cited by 59
Targeted therapies of cancer: Angiogenesis inhibition seems not enough
Roodink, I., & Leenders, W. P. J. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.09.004 · Cited by 57
Sonic Hedgehog in cancer stem cells: a novel link with autophagy
Milla, L. A., González-Ramírez, C. N., & Palma, V. (2012) · Biological Research · doi:10.4067/s0716-97602012000300004 · Cited by 59
Inhibitory effects of a gradient static magnetic field on normal angiogenesis
Wang, Z., Yang, P., Xu, H., Qian, A., Hu, L., & Shang, P. (2009) · Bioelectromagnetics · doi:10.1002/bem.20501 · Cited by 59
Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review
Kim, M., Lee, C., Payne, R. M., Yue, B. Y. J. T., Chang, J.-H., & Ying, H. (2015) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2015.04.003 · Cited by 60
Thombospondin-1 Disrupts Estrogen-Induced Endothelial Cell Proliferation and Migration and Its Expression Is Suppressed by Estradiol
Sengupta, K., Banerjee, S., Saxena, N. K., & Banerjee, S. K. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.150.2.3 · Cited by 59
MRI-Guided Clinical 6-MV Radiosensitization of Glioma Using a Unique Gadolinium-Based Nanoparticles Injection
Verry, C., Dufort, S., Barbier, E., Montigon, O., Péoc’h, M., Chartier, P., Lux, F., Balosso, J., Tillement, O., Sancey, L., et al. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0203 · Cited by 59
Keratin 19 as a key molecule in progression of human hepatocellular carcinomas through invasion and angiogenesis
Takano, M., Shimada, K., Fujii, T., Morita, K., Takeda, M., Nakajima, Y., Nonomura, A., Konishi, N., & Obayashi, C. (2016) · BMC Cancer · doi:10.1186/s12885-016-2949-y · Cited by 59

Authors: Bergers, G., & Benjamin, L. E.
Affiliations: University of California, San Francisco (US)
Beth Israel Deaconess Medical Center (US)
Corresponding author: Bergers, Gabriele
ORCID: Bergers, Gabriele
Venue: Nature reviews. Cancer
Publisher: Springer Science and Business Media LLC
Published: 2003-06
Volume: 3
Issue: 6
Pages: 401-410
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc1093
OpenAlex: W2804842145
Cited by: 3,559
References: 110
Citations by year: 2026: 53 · 2025: 79 · 2024: 123 · 2023: 122 · 2022: 142 · 2021: 160 · 2020: 149 · 2019: 159 · 2018: 162 · 2017: 176 · 2016: 148 · 2015: 176 · 2014: 232 · 2013: 223 · 2012: 198
FWCI: 9.49
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
Keywords: carcinogenesis, angiogenic switch, tumor angiogenesis, tumor vasculature, tumor microenvironment, tumor-stroma interactions, tumor progression, anti-angiogenic therapy, tumor recurrence
MeSH terms: Animals, Humans, Neoplasms, Neovascularization, Pathologic, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumorigenesis and the angiogenic switch

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks